Since obesity has been identified as a state of FGF-21 resistance [12], it is logical to speculate that the higher levels of circulating FGF-21 are partly driven by high adiposity that accompanies overweight and/or obesity. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.